Atorvastatin Calcium Tablet
Product Images NDC 60290-041

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60290-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Umedica Laboratories Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

"image Description" (Atorvastat Cal Usp Fig 1)

A line graph showing cumulative incidence percentage over 3.5 years comparing Atorvastatin and Placebo. The Atorvastatin group is represented by a solid line and shows a lower cumulative incidence compared to the placebo group, represented by a dashed line. The graph includes a hazard ratio of 0.64 with confidence interval 0.50 to 0.83 and a p-value of 0.0005.*

FDA Label Image

"image Description" (Atorvastat Cal Usp Fig 2)

A line graph showing cumulative hazard percentage over time in years for Atorvastatin compared to Placebo. The x-axis represents time to first primary endpoint through four years of follow-up, and the y-axis represents cumulative hazard percentage. Two lines depict hazard trends for Placebo and Atorvastatin groups, with Atorvastatin consistently lower than Placebo.*

FDA Label Image

"image Description" (Atorvastat Cal Usp Fig 3)

A line graph comparing the percentage of subjects experiencing the first major cardiovascular event over five years for Atorvastatin calcium 10 mg and 80 mg dosages. The x-axis represents time in years, and the y-axis shows the percentage of subjects experiencing the event. The 10 mg dose is depicted with a dotted line, and the 80 mg dose with a solid line, illustrating lower event rates over time for the 80 mg dose.*

FDA Label Image

"image Description" (Atorvastat Cal Usp Structure)

Chemical structure of atorvastatin calcium, showing the molecular arrangement with calcium ions and water molecules indicated, consistent with atorvastatin calcium trihydrate.*

FDA Label Image

"image Description" (Atorvastatin Cal Usp 10mg 1000s Label)

Label for Atorvastatin Calcium Tablets USP, 10 mg strength, oral tablets. The label indicates 1000 tablets per container and includes storage instructions to keep at controlled room temperature (20°C-25°C). It is manufactured by Umedica Laboratories Pvt. Ltd. in India and distributed by Umedica Laboratories USA Inc., Parsippany, NJ. The label also shows the NDC 60290-039-02 and has barcode and serialization information.*

FDA Label Image

"image Description" (Atorvastatin Cal Usp 10mg 90s Label)

Label for Atorvastatin Calcium Tablets, USP 10 mg oral tablets, containing 90 tablets per package. Manufactured by Umedica Laboratories Pvt. Ltd., India, and distributed by Umedica Laboratories USA Inc. Label includes dosage form, strength, packaging quantity, storage instructions, and barcode with product identifiers.*

FDA Label Image

"image Description" (Atorvastatin Cal Usp 20mg 1000s Label)

Label for Atorvastatin Calcium Tablets, USP 20 mg, oral tablet by Umedica Laboratories USA Inc. The label states each tablet contains 20 mg Atorvastatin Calcium equivalent, storage instructions, and dispensing guidelines. It shows a package count of 1000 tablets, barcodes, manufacturing details from Umedica Laboratories Pvt. Ltd., India, and a reminder to see the package insert for dosing information.*

FDA Label Image

"image Description" (Atorvastatin Cal Usp 20mg 90s Label)

Atorvastatin Calcium Tablets USP 20 mg oral tablets label showing 90 tablets per container. The label states storage instructions at controlled room temperature (20°C-25°C), manufacturer Umedica Laboratories Pvt. Ltd., India, and distributor Umedica Laboratories USA Inc., Parsippany, NJ. It includes NDC 60290-040-01, barcode, and prescription only marking.*

FDA Label Image

"image Description" (Atorvastatin Cal Usp 40mg 1000s Label)

Atorvastatin Calcium Tablets USP 40 mg oral tablets packaging label displaying the product name, strength, and quantity of 1000 tablets. Manufactured by Umedica Laboratories Pvt. Ltd. in India and distributed by Umedica Laboratories USA Inc. The label includes storage instructions, dosage direction references, and regulatory information including NDC 60290-041-04.*

FDA Label Image

"image Description" (Atorvastatin Cal Usp 40mg 90s Label)

Label for Atorvastatin Calcium Tablets USP 40 mg oral tablets. The label states each tablet contains 40 mg Atorvastatin Calcium USP, with storage instructions at 20°C-25°C (68°F-77°F). It mentions the product is manufactured by Umedica Laboratories Pvt. Ltd. in India and distributed by Umedica Laboratories USA Inc., Parsippany, NJ. The package contains 90 tablets and is labeled Rx only.*

FDA Label Image

"image Description" (Atorvastatin Cal Usp 80mg 1000s Label)

Atorvastatin Calcium Tablets USP 80 mg oral tablets label showing the NDC 60290-042-04. The label states the product contains Atorvastatin Calcium USP equivalent to 80 mg Atorvastatin per tablet. It is distributed by Umedica Laboratories USA Inc. and manufactured in India by Umedica Laboratories Pvt. Ltd. The package size is 1000 tablets, with storage instructions at controlled room temperature (20°C-25°C).*

FDA Label Image

"image Description" (Atorvastatin Cal Usp 80mg 90s Label)

Label for Atorvastatin Calcium Tablets USP 80 mg, oral tablets. The label states 90 tablets per package and is labeled Rx only. Manufactured by Umedica Laboratories Pvt. Ltd., India, and distributed by Umedica Laboratories USA Inc., Parsippany, NJ. Storage and use instructions are included along with a barcode and product identification numbers.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.